249 related articles for article (PubMed ID: 8881668)
1. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
Collins P; Wainwright NJ; Amorim I; Lakshmipathi T; Ferguson J
Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
[TBL] [Abstract][Full Text] [Related]
2. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
[TBL] [Abstract][Full Text] [Related]
3. Twice- vs. thrice-weekly MPD PUVA in psoriasis: a randomized-controlled efficacy study.
Valbuena MC; Hernández O; Rey M; Sánchez G; de Quintana LP
Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):126-9. PubMed ID: 17598865
[TBL] [Abstract][Full Text] [Related]
4. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
Trott J; Gerber W; Hammes S; Ockenfels HM
Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
[TBL] [Abstract][Full Text] [Related]
6. Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis.
Kirby B; Buckley DA; Rogers S
Br J Dermatol; 1999 Apr; 140(4):661-6. PubMed ID: 10233317
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
Cox NH; Farr PM; Diffey BL
Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
[TBL] [Abstract][Full Text] [Related]
8. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
Nimkulrat P; Leenutaphong V; Sudtim S
J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
[TBL] [Abstract][Full Text] [Related]
9. Bath PUVA and psoriasis: is a milder treatment a worse treatment?
Delrosso G; Bornacina C; Farinelli P; Bellinzona F; Leigheb G; Colombo E
Dermatology; 2008; 216(3):191-3. PubMed ID: 18182808
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of psoralen - UVA photochemotherapy versus narrow band UVB phototherapy in the treatment of psoriasis.
Tahir R; Mujtaba G
J Coll Physicians Surg Pak; 2004 Oct; 14(10):593-5. PubMed ID: 15456547
[TBL] [Abstract][Full Text] [Related]
11. A comparison of twice-weekly MPD-PUVA and three times-weekly skin typing-PUVA regimens for the treatment of psoriasis.
Buckley DA; Healy E; Rogers S
Br J Dermatol; 1995 Sep; 133(3):417-22. PubMed ID: 8546997
[TBL] [Abstract][Full Text] [Related]
12. Determination of the minimal phototoxic dose and colorimetry in psoralen plus ultraviolet A radiation therapy.
Kraemer CK; Menegon DB; Cestari TF
Photodermatol Photoimmunol Photomed; 2005 Oct; 21(5):242-8. PubMed ID: 16149936
[TBL] [Abstract][Full Text] [Related]
13. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B.
Coven TR; Burack LH; Gilleaudeau R; Keogh M; Ozawa M; Krueger JG
Arch Dermatol; 1997 Dec; 133(12):1514-22. PubMed ID: 9420535
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses.
Engin B; Oguz O
Int J Dermatol; 2005 Apr; 44(4):337-9. PubMed ID: 15811091
[TBL] [Abstract][Full Text] [Related]
15. Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis.
Taibjee SM; Cheung ST; Laube S; Lanigan SW
Br J Dermatol; 2005 Nov; 153(5):960-6. PubMed ID: 16225606
[TBL] [Abstract][Full Text] [Related]
16. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
[TBL] [Abstract][Full Text] [Related]
18. Comparison of minimal phototoxic dose and skin type for determining initial UVA dose in oral liquid methoxsalen photochemotherapy for the treatment of psoriasis.
Rafal ES; Hamilton TA; Gonzalez E
J Invest Dermatol; 1991 Dec; 97(6):1048-52. PubMed ID: 1748814
[TBL] [Abstract][Full Text] [Related]
19. Narrowband ultraviolet B therapy in psoriasis: randomized double-blind comparison of high-dose and low-dose irradiation regimens.
Kleinpenning MM; Smits T; Boezeman J; van de Kerkhof PC; Evers AW; Gerritsen MJ
Br J Dermatol; 2009 Dec; 161(6):1351-6. PubMed ID: 19466961
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
Berne B; Fischer T; Michaëlsson G; Norén P
Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
